Trade Groups, Drugmakers Co-Sign Pfizer’s Petition on Misleading Claims About Biosimilars

Drug Industry Daily
A A
Several pharma industry trade groups and drugmakers wrote to the FDA to endorse a Pfizer petition asking the agency to take more aggressive steps against biosimilar-related misinformation.

To View This Article:

Login

Subscribe To Drug Industry Daily